Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

This category includes several serum cytokines (IL-10, CCL2, IFN-γ, IFN-α, IL-2) as well as C-reactive protein (CRP), neutrophil gelatinase-associated lipocalin (NGAL), 25-hydroxyvitamin D (25(OH)D), myostatin (MSTN), hyaluronic acid (HA), soluble triggering receptors expressed on myeloid cells-1 (sTREM-1), circulating immune complexes (CICs), dexamethasone-induced protein (DEXI), and the redox biomarkers glutathione reductase (GSHred), advanced oxidation protein products (AOPP), and superoxide dismutase (SOD).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis not reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

No meta-analysis was performed.

Source: Methods.

Biomarkers of equine asthma: A review of the current literature

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Biomarkers of equine asthma: A review of the current literature

Review / evidence synthesis · Veterinary Research Communications · 2026

Original publication title

Biomarkers of equine asthma: A review of the current literature

Dorota Długopolska; Natalia Siwińska; Agnieszka Noszczyk-Nowak; Artur Niedźwiedź; Agnieszka Żak-Bochenek

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Equine Asthma (EA) is a common, lower airway disease. Yet current diagnostic standards rely on bronchoalveolar lavage fluid (BALF) cytology, which is moderately invasive and not always feasible in field conditions. This review aimed to synthesize current evidence on candidate biomarkers of EA, with a primary focus on blood-based matrices and BALF, while also including data on biomarkers measured in tracheal wash (TW), saliva and exhaled breath condensate (EBC), where available. Searches were performed in PubMed, Scopus and Google Scholar, and original studies in horses with mild-to-moderate or severe EA reporting potential biomarkers were included.

Across 57 unique studies, a broad spectrum of candidate biomarkers was evaluated. Blood-derived biomarkers, including surfactant protein D (SP-D), secretoglobin (SCGB), haptoglobin showed variable but generally limited specificity when assessed individually, although several combinations improved diagnostic accuracy. BALF-derived biomarkers more consistently reflected local airway inflammation and disease severity. Among these, neutrophil extracellular traps (NETs) related markers, neutrophil gelatinase-associated lipocalin (NGAL) and allergen-specific IgE profiles emerged as the most promising candidates, particularly in multimarker panels and phenotype-stratified analyses. Overall, current evidence supports the potential of integrated biomarker panels, especially those derived from BALF and complemented by blood-based markers, to refine the diagnosis and monitoring of EA, but robust validation in large, well-characterised study group is still required before routine clinical implementation.

Authors’ abstract

Equine Asthma (EA) is a common, lower airway disease. Yet current diagnostic standards rely on bronchoalveolar lavage fluid (BALF) cytology, which is moderately invasive and not always feasible in field conditions. This review aimed to synthesize current evidence on candidate biomarkers of EA, with a primary focus on blood-based matrices and BALF, while also including data on biomarkers measured in tracheal wash (TW), saliva and exhaled breath condensate (EBC), where available. Searches were performed in PubMed, Scopus and Google Scholar, and original studies in horses with mild-to-moderate or severe EA reporting potential biomarkers were included.

Across 57 unique studies, a broad spectrum of candidate biomarkers was evaluated. Blood-derived biomarkers, including surfactant protein D (SP-D), secretoglobin (SCGB), haptoglobin showed variable but generally limited specificity when assessed individually, although several combinations improved diagnostic accuracy. BALF-derived biomarkers more consistently reflected local airway inflammation and disease severity. Among these, neutrophil extracellular traps (NETs) related markers, neutrophil gelatinase-associated lipocalin (NGAL) and allergen-specific IgE profiles emerged as the most promising candidates, particularly in multimarker panels and phenotype-stratified analyses. Overall, current evidence supports the potential of integrated biomarker panels, especially those derived from BALF and complemented by blood-based markers, to refine the diagnosis and monitoring of EA, but robust validation in large, well-characterised study group is still required before routine clinical implementation.

Publication and source details

Original title: Biomarkers of equine asthma: A review of the current literature

Dorota Długopolska; Natalia Siwińska; Agnieszka Noszczyk-Nowak; Artur Niedźwiedź; Agnieszka Żak-Bochenek

Veterinary Research Communications · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T22:15:32.257484+00:00

DOI: 10.1007/s11259-026-11353-7 · PMC13294254